Mona Khoury
Primary Podiatric Medicine · Baldwin, NYNPI 1417030412
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Comsort, Inc at 46.9% of the total. That places this record below the midpoint for primary podiatric medicine clinicians in NY, where the typical reported total is $383.
Across 5 payments — averaging $42.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Comsort, Inc$100
- DJO, LLC$83
- Sandoz$19
- Terumo Medical Corporation$11
What the payments were for
- Consulting fees$10047%
- Travel & lodging$6530%
- Food & beverage$4823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Comsort, Inc | 1 | $100 |
| DJO, LLC | 2 | $83 |
| Sandoz | 1 | $19 |
| Terumo Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIVEXTRO$100
How this compares
$213 in reported general payments places this provider in the 35th percentile of 85 primary podiatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 13 | $27,611 |
| Diclofenac Epolamine | 11 | $3,890 |
| Diclofenac Sodium | 12 | $2,885 |
| Ammonium Lactate | 95 | $1,826 |
| Clotrimazole | 42 | $1,549 |
| Econazole Nitrate | 54 | $1,019 |
| SsdSilver Sulfadiazine | 15 | $697 |
| Ciclopirox | 27 | $678 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $410 |
| Silver Sulfadiazine | 14 | $392 |
| Ketoconazole | 12 | $279 |
| Naproxen | 13 | $232 |
| Ibuprofen | 26 | $157 |
| Montelukast Sodium | 12 | $154 |
| Gabapentin | 13 | $126 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Baldwin
- Anthony IorioNorth Salem$177K
- Brian StraussYonkers$20K
- Martin WendelkenBronx$14K
- Nicholas MegdanisBayside$12K
- Carlos SilvaWoodhaven$5K
- Edgard NauNew York$5K
- Roy DefrancisCheektowaga$4K
- Allen FungStaten Island$4K
- Lina DobronevskyManhasset$4K
- Michael MerensteinBronx$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.